NO20060821L - Heparin-derived oligosaccharide compositions, their preparation and pharmaceutical compositions containing said compositions - Google Patents
Heparin-derived oligosaccharide compositions, their preparation and pharmaceutical compositions containing said compositionsInfo
- Publication number
- NO20060821L NO20060821L NO20060821A NO20060821A NO20060821L NO 20060821 L NO20060821 L NO 20060821L NO 20060821 A NO20060821 A NO 20060821A NO 20060821 A NO20060821 A NO 20060821A NO 20060821 L NO20060821 L NO 20060821L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- heparin
- preparation
- derived oligosaccharide
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Det er beskrevet heparinavledede oligosakkaridblandinger som har en midlere molekylvekt fra 1800 til 2400 dalton og som er kjennetegnet ved en høy aXa aktivitet og ved fravær av alla aktivitet. Det er også beskrevet fremgangsmåte for fremstilling derav og farmasøytiske preparater inneholdende nevnte blandinger.Heparin-derived oligosaccharide compositions are described which have an average molecular weight from 1800 to 2400 daltons and which are characterized by a high aXa activity and in the absence of all activity. There is also described a process for their preparation and pharmaceutical compositions containing said compositions.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0309041A FR2857971B1 (en) | 2003-07-24 | 2003-07-24 | MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| PCT/FR2004/001943 WO2005010051A2 (en) | 2003-07-24 | 2004-07-22 | Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060821L true NO20060821L (en) | 2006-04-20 |
Family
ID=33561051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060821A NO20060821L (en) | 2003-07-24 | 2006-02-20 | Heparin-derived oligosaccharide compositions, their preparation and pharmaceutical compositions containing said compositions |
Country Status (40)
| Country | Link |
|---|---|
| EP (1) | EP1651677B1 (en) |
| JP (1) | JP4865552B2 (en) |
| KR (1) | KR101125517B1 (en) |
| CN (1) | CN1852926B (en) |
| AR (1) | AR045917A1 (en) |
| AT (1) | ATE487741T1 (en) |
| AU (1) | AU2004259111B2 (en) |
| BR (1) | BRPI0412850A (en) |
| CA (1) | CA2533555A1 (en) |
| CR (1) | CR8201A (en) |
| CY (1) | CY1111165T1 (en) |
| DE (1) | DE602004030015D1 (en) |
| DK (1) | DK1651677T3 (en) |
| EC (1) | ECSP066305A (en) |
| ES (1) | ES2355827T3 (en) |
| FR (1) | FR2857971B1 (en) |
| GT (1) | GT200400145A (en) |
| HK (1) | HK1094806A1 (en) |
| HN (1) | HN2004000250A (en) |
| IL (1) | IL173206A (en) |
| MA (1) | MA27928A1 (en) |
| ME (1) | MEP11608A (en) |
| MX (1) | MXPA06000336A (en) |
| MY (1) | MY136769A (en) |
| NO (1) | NO20060821L (en) |
| NZ (1) | NZ544717A (en) |
| OA (1) | OA13197A (en) |
| PA (1) | PA8606801A1 (en) |
| PE (1) | PE20050246A1 (en) |
| PL (1) | PL1651677T3 (en) |
| PT (1) | PT1651677E (en) |
| RS (1) | RS20060044A (en) |
| RU (1) | RU2346005C2 (en) |
| SI (1) | SI1651677T1 (en) |
| TN (1) | TNSN06025A1 (en) |
| TW (1) | TWI369208B (en) |
| UA (1) | UA89356C2 (en) |
| UY (1) | UY28435A1 (en) |
| WO (1) | WO2005010051A2 (en) |
| ZA (1) | ZA200600657B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7589145B2 (en) | 2004-04-15 | 2009-09-15 | Exxonmobil Chemical Patents Inc. | Syndiotactic rich polyolefins |
| CN101495517B (en) * | 2006-05-25 | 2012-10-10 | 莫曼塔医药品有限公司 | Low molecular weight heparin composition and uses thereof |
| CN101711771B (en) * | 2008-10-07 | 2015-12-09 | 上海喜恩医药科技发展有限公司 | A kind of polysaccharide mixture of heparin derivative and method for making thereof and pharmaceutical composition |
| CA3020369C (en) * | 2010-09-14 | 2019-11-26 | University Of Miyazaki | High purity heparin and production method therefor |
| WO2012072799A1 (en) | 2010-12-02 | 2012-06-07 | Aventis Pharma S.A. | New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample |
| CN102558392A (en) * | 2010-12-14 | 2012-07-11 | 王芃 | Preparation method of high-FXa-resistant low-FIIa-resistant low-molecular heparin sodium |
| CN102816255B (en) * | 2011-06-10 | 2015-11-25 | 王芃 | A kind of preparation method of ultra-low molecular heparin sodium |
| WO2014153995A1 (en) * | 2013-03-26 | 2014-10-02 | 中国科学院昆明植物研究所 | Low molecular weight glycosaminoglycan derivative, pharmaceutical composition thereof, preparation method therefor and use thereof |
| CN103864959A (en) * | 2014-04-03 | 2014-06-18 | 中国药科大学 | Application of heparin oligosaccharide dp12 in atherosclerosis resistance |
| RU2639574C2 (en) * | 2016-05-23 | 2017-12-21 | Алексей Георгиевич Александров | Process for low molecular weight heparin preparation |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL61201A (en) * | 1979-10-05 | 1984-09-30 | Choay Sa | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them |
| FR2504928A1 (en) * | 1981-04-29 | 1982-11-05 | Choay Sa | SHORT CHAIN OLIGOSACCHARIDES HAVING BIOLOGICAL PROPERTIES, PREPARATION THEREOF AND APPLICATIONS THEREOF AS MEDICAMENTS |
| WO1998055515A1 (en) * | 1997-06-06 | 1998-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Modified low molecular weight heparin that inhibits clot associated coagulation factors |
| ES2161615B1 (en) * | 1999-07-23 | 2003-03-16 | Rovi Lab Farmaceut Sa | COMPOSITIONS OF HEPARINS OF VERY LOW MOLECULAR WEIGHT. |
| JP4897991B2 (en) * | 1999-07-23 | 2012-03-14 | ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ | Ultra low molecular weight heparin composition |
| FR2800074B1 (en) * | 1999-10-22 | 2001-12-21 | Aventis Pharma Sa | NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| JP4585072B2 (en) * | 2000-02-29 | 2010-11-24 | 扶桑薬品工業株式会社 | Heparin depolymerization method, depolymerized heparin, derivatives thereof and pharmaceutical composition |
| FR2807043B1 (en) * | 2000-03-28 | 2002-11-22 | Aventis Pharma Sa | PHARMACEUTICAL COMPOSITION CONTAINING OLIGOSACCHARIDES, NEW OLIGOSACCHARIDES AND THEIR PREPARATION |
| FR2811992B1 (en) * | 2000-07-21 | 2003-07-04 | Aventis Pharma Sa | MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US6969705B2 (en) * | 2000-07-21 | 2005-11-29 | Aventis Pharma S.A. | Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| WO2003018032A1 (en) * | 2001-08-28 | 2003-03-06 | Leo Pharma A/S | Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate |
| FR2845686B1 (en) * | 2002-10-10 | 2013-08-30 | Aventis Pharma Sa | MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
2003
- 2003-07-24 FR FR0309041A patent/FR2857971B1/en not_active Expired - Fee Related
-
2004
- 2004-07-01 PE PE2004000632A patent/PE20050246A1/en not_active Application Discontinuation
- 2004-07-14 PA PA20048606801A patent/PA8606801A1/en unknown
- 2004-07-19 AR ARP040102549A patent/AR045917A1/en not_active Application Discontinuation
- 2004-07-21 HN HN2004000250A patent/HN2004000250A/en unknown
- 2004-07-22 AT AT04785991T patent/ATE487741T1/en active
- 2004-07-22 RS YUP-2006/0044A patent/RS20060044A/en unknown
- 2004-07-22 AU AU2004259111A patent/AU2004259111B2/en not_active Ceased
- 2004-07-22 NZ NZ544717A patent/NZ544717A/en unknown
- 2004-07-22 PT PT04785991T patent/PT1651677E/en unknown
- 2004-07-22 DE DE602004030015T patent/DE602004030015D1/en active Active
- 2004-07-22 UA UAA200601969A patent/UA89356C2/en unknown
- 2004-07-22 ME MEP-116/08A patent/MEP11608A/en unknown
- 2004-07-22 JP JP2006520862A patent/JP4865552B2/en not_active Expired - Fee Related
- 2004-07-22 WO PCT/FR2004/001943 patent/WO2005010051A2/en active Application Filing
- 2004-07-22 BR BRPI0412850-8A patent/BRPI0412850A/en active Search and Examination
- 2004-07-22 ES ES04785991T patent/ES2355827T3/en active Active
- 2004-07-22 OA OA1200600025A patent/OA13197A/en unknown
- 2004-07-22 PL PL04785991T patent/PL1651677T3/en unknown
- 2004-07-22 MY MYPI20042944A patent/MY136769A/en unknown
- 2004-07-22 DK DK04785991.3T patent/DK1651677T3/en active
- 2004-07-22 CN CN2004800265420A patent/CN1852926B/en not_active Expired - Fee Related
- 2004-07-22 KR KR1020067001609A patent/KR101125517B1/en not_active IP Right Cessation
- 2004-07-22 MX MXPA06000336A patent/MXPA06000336A/en active IP Right Grant
- 2004-07-22 EP EP04785991A patent/EP1651677B1/en active Active
- 2004-07-22 SI SI200431594T patent/SI1651677T1/en unknown
- 2004-07-22 CA CA002533555A patent/CA2533555A1/en not_active Abandoned
- 2004-07-22 RU RU2006105384/04A patent/RU2346005C2/en not_active IP Right Cessation
- 2004-07-23 GT GT200400145A patent/GT200400145A/en unknown
- 2004-07-23 TW TW093121979A patent/TWI369208B/en not_active IP Right Cessation
- 2004-07-23 UY UY28435A patent/UY28435A1/en unknown
-
2006
- 2006-01-17 IL IL173206A patent/IL173206A/en not_active IP Right Cessation
- 2006-01-18 CR CR8201A patent/CR8201A/en unknown
- 2006-01-20 MA MA28745A patent/MA27928A1/en unknown
- 2006-01-23 TN TNP2006000025A patent/TNSN06025A1/en unknown
- 2006-01-23 EC EC2006006305A patent/ECSP066305A/en unknown
- 2006-01-23 ZA ZA200600657A patent/ZA200600657B/en unknown
- 2006-02-20 NO NO20060821A patent/NO20060821L/en not_active Application Discontinuation
-
2007
- 2007-01-10 HK HK07100324.0A patent/HK1094806A1/en not_active IP Right Cessation
-
2011
- 2011-02-04 CY CY20111100132T patent/CY1111165T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060821L (en) | Heparin-derived oligosaccharide compositions, their preparation and pharmaceutical compositions containing said compositions | |
| NO20082709L (en) | Chemical connections | |
| NO20071610L (en) | Immunogenic composition | |
| NO20082265L (en) | Dispersible tablets including deferasirox | |
| NO20083845L (en) | 2,4-diaminopyrimidines as cell cycle kinase inhibitors | |
| ATE409048T1 (en) | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | |
| NO20070434L (en) | Polysaccharide derivatives and applications in the induction of an immune response | |
| NO20074703L (en) | Antibacterial piperidine derivatives | |
| ATE510546T1 (en) | SULFUFATED DEPOLYMERIZED EXOPOLYSACCHARIDE DERIVATIVES, THEIR PREPARATION AND USES | |
| NO20073719L (en) | Chemical connections | |
| NO20076059L (en) | 2,4-Diamino-pyrimidines used as aurora inhibitors | |
| NO20071776L (en) | Kinoxalines as B RAF inhibitors. | |
| NO20044618L (en) | Dedifferentiated, programmable monocytic stem cells and their preparation and use | |
| BRPI0508144A (en) | sulfated oligosaccharide derivatives composed of the general formula; pharmaceutical or veterinary composition its use; method for the prevention or treatment by using it | |
| NO20002605D0 (en) | Speroids, method of preparation and pharmaceutical compositions | |
| NO20090469L (en) | Substituted piperidines which increase P53 activity and use thereof | |
| NO20072939L (en) | Macrolones - amino-substituted quinolones | |
| NO20080875L (en) | New macrocyclic inhibitors of hepatitis C virus replication | |
| NO20061657L (en) | Pyrol derivatives with antibacterial activity | |
| WO2008013987A3 (en) | N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones | |
| MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
| MY142376A (en) | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them | |
| EP1561760A3 (en) | Low molecular weight heparin salt with thriethanolamine | |
| DK1965809T3 (en) | Compositions for improving animal health and animal performance including Beta-glucans and Alpha-Fucans | |
| ITMI20031618A1 (en) | POLYSACCHARIDE DERIVATIVES EQUIPPED WITH HIGH ACTIVITY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |